Phathom Pharmaceuticals Statistics
Total Valuation
PHAT has a market cap or net worth of $921.39 million. The enterprise value is $1.30 billion.
Important Dates
The last earnings date was Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PHAT has 79.43 million shares outstanding. The number of shares has increased by 13.31% in one year.
| Current Share Class | 79.43M |
| Shares Outstanding | 79.43M |
| Shares Change (YoY) | +13.31% |
| Shares Change (QoQ) | +11.15% |
| Owned by Insiders (%) | 3.44% |
| Owned by Institutions (%) | 56.40% |
| Float | 60.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 32.31 |
| PS Ratio | 4.56 |
| Forward PS | 2.40 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.21
| Current Ratio | 2.21 |
| Quick Ratio | 2.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.47 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -20.15% |
| Return on Invested Capital (ROIC) | -27.66% |
| Return on Capital Employed (ROCE) | -53.64% |
| Weighted Average Cost of Capital (WACC) | 8.16% |
| Revenue Per Employee | $552,270 |
| Profits Per Employee | -$423,989 |
| Employee Count | 371 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 6.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +170.39% in the last 52 weeks. The beta is 0.57, so PHAT's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +170.39% |
| 50-Day Moving Average | 11.72 |
| 200-Day Moving Average | 12.81 |
| Relative Strength Index (RSI) | 48.11 |
| Average Volume (20 Days) | 1,454,827 |
Short Selling Information
The latest short interest is 9.74 million, so 12.26% of the outstanding shares have been sold short.
| Short Interest | 9.74M |
| Short Previous Month | 9.50M |
| Short % of Shares Out | 12.26% |
| Short % of Float | 16.18% |
| Short Ratio (days to cover) | 7.27 |
Income Statement
In the last 12 months, PHAT had revenue of $204.89 million and -$157.30 million in losses. Loss per share was -$2.09.
| Revenue | 204.89M |
| Gross Profit | 174.02M |
| Operating Income | -96.60M |
| Pretax Income | -157.30M |
| Net Income | -157.30M |
| EBITDA | -96.03M |
| EBIT | -96.60M |
| Loss Per Share | -$2.09 |
Full Income StatementBalance Sheet
The company has $180.90 million in cash and $547.22 million in debt, with a net cash position of -$366.31 million or -$4.61 per share.
| Cash & Cash Equivalents | 180.90M |
| Total Debt | 547.22M |
| Net Cash | -366.31M |
| Net Cash Per Share | -$4.61 |
| Equity (Book Value) | -336.96M |
| Book Value Per Share | -4.24 |
| Working Capital | 151.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$97.49 million and capital expenditures -$272,000, giving a free cash flow of -$97.76 million.
| Operating Cash Flow | -97.49M |
| Capital Expenditures | -272,000 |
| Depreciation & Amortization | 566,000 |
| Net Borrowing | -55.80M |
| Free Cash Flow | -97.76M |
| FCF Per Share | -$1.23 |
Full Cash Flow StatementMargins
Gross margin is 84.93%, with operating and profit margins of -47.15% and -76.77%.
| Gross Margin | 84.93% |
| Operating Margin | -47.15% |
| Pretax Margin | -76.77% |
| Profit Margin | -76.77% |
| EBITDA Margin | -46.87% |
| EBIT Margin | -47.15% |
| FCF Margin | n/a |
Dividends & Yields
PHAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.31% |
| Shareholder Yield | -13.31% |
| Earnings Yield | -16.84% |
| FCF Yield | -10.47% |
Analyst Forecast
The average price target for PHAT is $23.70, which is 104.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.70 |
| Price Target Difference | 104.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 22.57% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PHAT has an Altman Z-Score of -6 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6 |
| Piotroski F-Score | 3 |
